Intrauterine Device
11
1
1
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
9.1%
1 terminated out of 11 trials
88.9%
+2.4% vs benchmark
27%
3 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (11)
Can Uterocervical Angle Predict the Displacement of Copper Intrauterine Devices (T-Cu 380A)
Structured Contraceptive Counseling During Pregnancy
MUSIC Prior to a T380A Intrauterine Device Insertion in Nulliparous Women.
The Effect of Virtual Reality on Anxiety During Intrauterine Device Insertion
Study to Evaluate the Learning Curve to Anchor GYN-CS® Device
Intrauterine Device Insertion: a Step for High Satisfaction
Misoprostol for Cervical Ripening Before Copper Intrauterine Device Removal
Vaginal Dinoprostone Administration Prior to a T380A Intrauterine Device Insertion in Nulliparous Women.
10% Lidocaine Spray for Intrauterine Device Insertion
Vaginal Dinoprostone Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System in Women With no Previous Vaginal Delivery
Cold Compress for Pain Associated With Intrauterine Device Insertion